Last reviewed · How we verify
Acute myelogenous leukemia
Approved treatments
- Cyclophosphamid · Zhejiang University
- Cytoxan (Lyophilized) · Baxter
Cyclophosphamide cross-links tumor cell DNA and interferes with malignant cell growth through active alkylating metabolites. - Cytoxan (Lyophilized) · Baxter
Cytoxan works by interfering with the DNA replication process in rapidly dividing cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute myelogenous leukemia patent landscape — cliff calendar, originator estates, attackable patents
- Acute myelogenous leukemia treatment landscape brief
- Acute myelogenous leukemia treatment updates RSS
Frequently asked questions about Acute myelogenous leukemia
What drugs treat Acute myelogenous leukemia?
Tracked treatments include Cyclophosphamid, Cytoxan (Lyophilized).
What is the treatment for Acute myelogenous leukemia?
Standard treatment for Acute myelogenous leukemia includes Cyclophosphamid, Cytoxan (Lyophilized). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute myelogenous leukemia patent cliff · Acute myelogenous leukemia CI report
- Treatment: Cyclophosphamid · Zhejiang University
- Treatment: Cytoxan (Lyophilized) · Baxter
- Treatment: Cytoxan (Lyophilized) · Baxter
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing